DRUG: Tasonermin Help Entry D08562                      Drug                                    Name Tasonermin (INN); Beromun (TN) Formula C778H1225N215O231S2 Exact mass 17340.016 Mol weight 17350.483 Remark ATC code:  L03AX11 Efficacy Antineoplastic Comment recombinant human TNF-alpha [HSA:7124] [KO:K03156] Target TNFRSF1 (CD120) [HSA:7132 7133] [KO:K03158 K05141]   Pathway hsa04060   Cytokine-cytokine receptor interaction hsa04064   NF-kappa B signaling pathway hsa04668   TNF signaling pathway Brite Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]  L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS   L03 IMMUNOSTIMULANTS    L03A IMMUNOSTIMULANTS     L03AX Other immunostimulants      L03AX11 Tasonermin       D08562  Tasonermin (INN) Target-based classification of drugs [BR:br08310]  Cytokines and receptors   Cytokine receptors    Tumor necrosis factor receptors     TNFRSF1 (CD120)      D08562  Tasonermin (INN) New drug approvals in Europe [br08329.html]  European public assessment reports (EPAR) authorised medicine   D08562 BRITE hierarchy Other DBs CAS:  94948-59-1 PubChem:  96025247 LinkDB All DBs » Japanese version   » Back

DBGET integrated database retrieval system